Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Vaccines made from a person's tumor cells and white blood cells may make the body
build an immune response to kill tumor cells. Drugs used in chemotherapy, such as
fludarabine, work in different ways to stop tumor cells from dividing so they stop growing or
die. Combining vaccine therapy with fludarabine may kill more tumor cells.
PURPOSE: This randomized phase II trial is studying vaccine therapy and fludarabine to see
how well they work compared to vaccine therapy alone in treating patients with stage IV
kidney cancer.